Paul Hopper, Chairman at Imugene Limited, holds 194.99M shares in Chimeric Therapeutics Ltd. (Ticker: AU:CHM), holds 147.72M shares in Radiopharm Theranostics Limited (Ticker: AU:RAD), holds 409.07M shares in Imugene Limited (Ticker: IUGNF). Most recently, Paul Hopper Bought ― shares of Chimeric Therapeutics Ltd. on Dec 13, 2024 for an estimated value of 800.00K.
Paul Hopper latest transaction was an Informative Buy of AU$800.00K.
What was Paul Hopper's most profitable transaction?
Paul Hopper’s most profitable transaction was an Informative Sell of IUGNF stock on December 13, 2021. The return on the trade was 67.10%.
What is Paul Hopper's role in Imugene Limited?
Paul Hopper's role in Imugene Limited is Chairman.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.